Aug 14, 2024 4:10 pm EDT VolitionRx Limited Announces Second Quarter 2024 Financial Results and Business Update
Aug 9, 2024 8:00 am EDT VolitionRx Announces Pricing of up to $21.5 Million Registered Direct Offering
Aug 6, 2024 8:00 am EDT VolitionRx Limited Schedules Second Quarter 2024 Earnings Conference Call and Business Update
Jul 9, 2024 8:30 am EDT Volition appoints PharmaVentures for Capture PCR™ and oncology portfolio licensing
May 13, 2024 4:10 pm EDT VolitionRx Limited Announces First Quarter 2024 Financial Results and Business Update
May 8, 2024 8:00 am EDT VolitionRx Limited Schedules First Quarter 2024 Earnings Conference Call and Business Update
